1. Home
  2. GGAL vs BIO Comparison

GGAL vs BIO Comparison

Compare GGAL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Financiero Galicia S.A.

GGAL

Grupo Financiero Galicia S.A.

HOLD

Current Price

$42.93

Market Cap

7.2B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$269.19

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGAL
BIO
Founded
1905
1952
Country
Argentina
United States
Employees
10098
7450
Industry
Commercial Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GGAL
BIO
Price
$42.93
$269.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$69.00
$358.50
AVG Volume (30 Days)
1.2M
269.9K
Earning Date
03-07-2023
04-30-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$50.99
$2.74
Revenue Next Year
N/A
$3.05
P/E Ratio
$13.36
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$25.89
$211.43
52 Week High
$66.24
$343.12

Technical Indicators

Market Signals
Indicator
GGAL
BIO
Relative Strength Index (RSI) 44.01 47.03
Support Level $40.54 $266.71
Resistance Level $45.86 $289.61
Average True Range (ATR) 2.15 7.96
MACD 0.32 1.32
Stochastic Oscillator 37.90 57.07

Price Performance

Historical Comparison
GGAL
BIO

About GGAL Grupo Financiero Galicia S.A.

Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: